HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cleo-Aron Weis Selected Research

margatoxin

5/2018Thymectomy lowers the myasthenia gravis biomarker miR-150-5p.
1/2018Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
1/2018Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cleo-Aron Weis Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 01/2015
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 10/2016
5Carcinoma (Carcinomatosis)
01/2022 - 12/2018
5Colorectal Neoplasms (Colorectal Cancer)
07/2019 - 01/2017
4Myasthenia Gravis
05/2018 - 08/2015
3Neoplasm Metastasis (Metastasis)
06/2021 - 01/2017
3Thymoma (Thymic Carcinoma)
01/2021 - 02/2015
2Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2018
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 01/2022
2Prostatic Neoplasms (Prostate Cancer)
06/2020 - 01/2019
1Follicular Adenocarcinoma
08/2021
1Breast Neoplasms (Breast Cancer)
08/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Pancreatitis
01/2021
1Hyperplasia
06/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Adenocarcinoma
01/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019
1Carcinoid Tumor (Carcinoid)
01/2019
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019
1Lymphatic Metastasis
12/2018
1Merkel Cell Carcinoma
01/2018
1Skin Neoplasms (Skin Cancer)
01/2018
1Melanoma (Melanoma, Malignant)
11/2017
1Microvillus inclusion disease
07/2014

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2017
5Messenger RNA (mRNA)IBA
01/2021 - 01/2018
3Pharmaceutical PreparationsIBA
07/2019 - 01/2017
3margatoxinIBA
05/2018 - 01/2018
3Cholinergic ReceptorsIBA
05/2018 - 08/2015
2Coloring Agents (Dyes)IBA
08/2021 - 01/2015
2RNA (Ribonucleic Acid)IBA
04/2021 - 01/2018
2MicroRNAs (MicroRNA)IBA
01/2021 - 05/2018
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
2ParaffinIBA
01/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
11/2019 - 11/2017
1eltrombopagFDA Link
01/2022
11,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA
06/2021
1Cisplatin (Platino)FDA LinkGeneric
04/2021
1galactosylceramide sulfotransferaseIBA
01/2021
1Interleukin-22 (IL-22)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Long Noncoding RNAIBA
12/2020
1Biological ProductsIBA
12/2020
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
06/2020
1Microfilament Proteins (Actin Binding Proteins)IBA
11/2019
1Bevacizumab (Avastin)FDA Link
07/2019
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
07/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019
1SteroidsIBA
02/2019
1B7-H1 AntigenIBA
01/2019
1SynaptophysinIBA
01/2019
1Hematoxylin (Haematoxylon)IBA
01/2019
1Eosine Yellowish-(YS) (Eosin)IBA
01/2019
1ChromograninsIBA
01/2019
1Chromogranin AIBA
01/2019
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2018
1Keratins (Keratin)IBA
08/2018
1AntibodiesIBA
05/2018
1Fibroblast Growth Factor 3IBA
01/2018
1LigandsIBA
01/2018
1Prednisone (Sone)FDA LinkGeneric
01/2018
1Hyaluronic Acid (Hyaluronan)IBA
11/2017
1CytokinesIBA
11/2017
1Peptide Hydrolases (Proteases)FDA Link
11/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2017
1Peptide Elongation Factor 1 (EF-1)IBA
09/2017
1Phenobarbital (Luminal)FDA Link
01/2017
1Sunitinib (Sutent)FDA Link
02/2015
1A-factor (Streptomyces)IBA
01/2015
1Qa-SNARE Proteins (Syntaxin)IBA
07/2014

Therapy/Procedure

7Cystectomy
01/2022 - 10/2016
7Therapeutics
01/2021 - 01/2017
4Immunotherapy
01/2019 - 11/2017
3Drug Therapy (Chemotherapy)
04/2021 - 01/2017
3Thymectomy
05/2018 - 01/2018
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Radiotherapy
06/2021
1Prostatectomy (Retropubic Prostatectomy)
06/2020
1Intravenous Administration
01/2018
1Castration
03/2017
1Transplantation
08/2015